Selective estrogen receptor modulators: Women's panacea for the next millennium?

Citation
Cp. Spencer et al., Selective estrogen receptor modulators: Women's panacea for the next millennium?, AM J OBST G, 180(3), 1999, pp. 763-770
Citations number
120
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
ISSN journal
00029378 → ACNP
Volume
180
Issue
3
Year of publication
1999
Part
1
Pages
763 - 770
Database
ISI
SICI code
0002-9378(199903)180:3<763:SERMWP>2.0.ZU;2-9
Abstract
The purpose of this review is to assimilate relevant experimental and clini cal information available on selective estrogen receptor modulators with re spect to their potential use as agents to improve women's health in the pos tmenopausal years. In addition, the mechanisms of action of these drugs are outlined. Selective estrogen receptor modulators represent an exciting gro up of antiestrogens that possess agonist action on bone, lipids, and lipopr oteins and antagonistic action in the endometrium and breast. Thus in theor y these drugs may preserve bone density and reduce the risk of osteoporotic fracture and coronary heart disease at the same time that they lower the i ncidences of breast and endometrial neoplasms. Short-term data with the use of raloxifene suggest that bone is preserved and lipid profiles are less a therogenic. Long-term studies are needed to determine whether raloxifene or other selective estrogen receptor modulators are associated with any decre ase in the risk of breast or endometrial cancer.